Further unique features include no proximate adenoviral vaccine or adenovirus exposure, recent cytomegalovirus (CMV) infection and high‐titre anti‐PF4 antibody, detectable as a paraprotein. This evidence concerns the gene PF4 and cytomegalovirus infection.